Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV001811168 | SCV001159864 | pathogenic | not provided | 2023-10-27 | criteria provided, single submitter | clinical testing | The Hb Quong Sze variant (HBA2: c.377T>C; p.Leu126Pro, also known as Leu125Pro when numbered from the mature protein, rs41397847, HbVar ID: 187) is reported in the literature in multiple Chinese individuals and families affected with alpha thalassemia (see link to HbVar and references therein). This variant has been observed in the heterozygous state in individuals with a clinical presentation resembling alpha-thalassemia trait, and in the compound heterozygous state with other pathogenic hemoglobin variants in individuals affected with hemoglobin H disease (Ahmad 2013, Goossens 1982, He 2017, Li 2011, Li 2015, Liang 1994, Liao 2009, Shang 2017, Zhou 2016). In vitro/in vivo functional analyses demonstrate that the variant protein is turned over rapidly and interferes with the formation of hemoglobin tetramers (Liebhaber 1983). This variant is reported in ClinVar (Variation ID: 15630). This variant is found in the East Asian population with an overall allele frequency of 0.08% (13/18322 alleles, including a single homozygote) in the Genome Aggregation Database. Additionally, other variants at this codon Hb West-Einde (HbVar ID: 2592), and Hb Plasencia (HbVar ID: 1226) have been reported in individuals with mild to moderate anemia, microcytosis, and hypochromia (see links to HbVar and references therein). The leucine at codon 126 is weakly conserved, but computational analyses predict that this variant is deleterious (REVEL: 0.854). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/menu.html Ahmad R et al. Distribution of alpha thalassaemia gene variants in diverse ethnic populations in malaysia: data from the institute for medical research. Int J Mol Sci. 2013 Sep 10;14(9):18599-614. PMID: 24025420 Goossens M et al. Globin structural mutant alpha 125Leu leads to Pro is a novel cause of alpha-thalassaemia. Nature. 1982 Apr 29;296(5860):864-5. PMID: 7070526 He J et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017 Sep;19(9):1022-1031. PMID: 28125089 Li J et al. Phenotypic variability in a chinese family with nondeletional Hb H-Hb Quong Sze disease. Hemoglobin. 2011;35(4):430-3. PMID: 21797711 Li J et al. Identification of nondeletional a-thalassemia in a prenatal screening program by reverse dot-blot in southern China. Hemoglobin. 2015;39(1):42-5. PMID: 25523870 Liang R et al. Alpha and beta thalassaemia among Chinese children in Guangxi Province, P.R. China: molecular and haematological characterization. Br J Haematol. 1994 Feb;86(2):351-4. PMID: 7515267 Liao C et al. Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze. Ann Hematol. 2009 Nov;88(11):1145-7. PMID: 19259674 Liebhaber SA et al. alpha-Thalassemia caused by an unstable alpha-globin mutant. J Clin Invest. 1983 Mar;71(3):461-6. PMID: 6826718 Shang X et al. Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies. EBioMedicine. 2017 Sep;23:150-159. PMID: 28865746 Zhou JY et al. First Case of a Compound Heterozygosity for Two Nondeletional a-Thalassemia mutations, Hb Constant Spring and Hb Quong Sze. Hemoglobin. 2016 Jun;40(3):210-2. PMID: 26956449 |
| Fulgent Genetics, |
RCV002476982 | SCV002780035 | pathogenic | Heinz body anemia; alpha Thalassemia; Hemoglobin H disease; Erythrocytosis, familial, 7 | 2022-05-09 | criteria provided, single submitter | clinical testing | |
| Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001811168 | SCV004219830 | pathogenic | not provided | 2023-04-14 | criteria provided, single submitter | clinical testing | The c.377T>C (p.Leu126Pro) pathogenic variant (also known as Hb Quong Sze) is reported as being highly unstable (PMID: 6826718 (1983), 1726096 (1991)). The frequency of this variant in the general population, 0.00071 (13/18322 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. In the published literature, the variant has been reported in individuals who are compound heterozygous for this pathogenic variant and a large deletion that removes both of the alpha-globin genes from the alpha-globin gene cluster (e.g., the --SEA alpha-globin deletion) are reported as being affected by Hb H disease (PMID: 7070526 (1982), 7515267 (1994), 19259674 (2009)). |
| OMIM | RCV000016897 | SCV000037168 | other | Hemoglobin Quong Sze | 2013-03-28 | no assertion criteria provided | literature only | |
| Gene |
RCV000417220 | SCV000503051 | not provided | alpha Thalassemia | no assertion provided | literature only | ||
| Natera, |
RCV000417220 | SCV002093848 | pathogenic | alpha Thalassemia | 2021-01-08 | no assertion criteria provided | clinical testing |